Ester Vanni

10.7k total citations · 6 hit papers
34 papers, 7.9k citations indexed

About

Ester Vanni is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ester Vanni has authored 34 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 16 papers in Hepatology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ester Vanni's work include Liver Disease Diagnosis and Treatment (30 papers), Diet, Metabolism, and Disease (8 papers) and Liver Disease and Transplantation (7 papers). Ester Vanni is often cited by papers focused on Liver Disease Diagnosis and Treatment (30 papers), Diet, Metabolism, and Disease (8 papers) and Liver Disease and Transplantation (7 papers). Ester Vanni collaborates with scholars based in Italy, Australia and United States. Ester Vanni's co-authors include Elisabetta Bugianesi, Giulio Marchesini, Nicola Villanova, Rita Manini, Stefania Natale, Mario Rizzetto, Mario Rizzetto, Nazario Melchionda, Gabriele Forlani and Marco Lenzi and has published in prestigious journals such as Gastroenterology, Hepatology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ester Vanni

34 papers receiving 7.7k citations

Hit Papers

Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabo... 2002 2026 2010 2018 2003 2002 2005 2008 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
    2003 2.1k citations Giulio Marchesini, Elisabetta Bugianesi et al. Hepatology profile →
  2. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma
    2002 1.1k citations Elisabetta Bugianesi, Nicola Leone et al. Gastroenterology profile →
  3. A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease
    2005 544 citations Elisabetta Bugianesi, E. Gentilcore et al. The American Journal of Gastroenterology profile →
  4. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
    2008 530 citations Anna Ludovica Fracanzani, Luca Valenti et al. Hepatology profile →
  5. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
    2005 507 citations Nicola Villanova, Simona Moscatiello et al. Hepatology profile →
  6. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†
    2010 497 citations Luca Valenti, Ahmad Al‐Serri et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Vanni Italy 25 7.0k 3.5k 2.4k 1.2k 1.1k 34 7.9k
Stergios Kechagias Sweden 33 7.8k 1.1× 3.2k 0.9× 4.0k 1.7× 1.6k 1.3× 799 0.7× 113 8.7k
Yao‐Chang Liu United States 6 7.8k 1.1× 2.8k 0.8× 3.4k 1.5× 985 0.8× 861 0.8× 9 9.1k
Mattias Ekstedt Sweden 31 7.9k 1.1× 3.2k 0.9× 4.0k 1.7× 1.4k 1.1× 846 0.8× 102 8.7k
Shivakumar Chitturi Australia 25 4.4k 0.6× 2.1k 0.6× 1.5k 0.6× 845 0.7× 661 0.6× 40 5.5k
Aaron B. Koenig United States 12 7.8k 1.1× 3.2k 0.9× 3.3k 1.4× 1.2k 0.9× 862 0.8× 15 8.8k
Janus P. Ong United States 31 5.5k 0.8× 2.1k 0.6× 2.9k 1.2× 969 0.8× 683 0.6× 72 6.3k
Christine G. Janney United States 17 4.3k 0.6× 1.6k 0.5× 2.0k 0.8× 795 0.6× 474 0.4× 36 5.3k
Sven Francque Belgium 48 7.3k 1.0× 2.9k 0.8× 3.2k 1.3× 801 0.6× 1.0k 0.9× 194 9.1k
Paola Loria Italy 45 4.4k 0.6× 1.9k 0.5× 1.9k 0.8× 694 0.6× 568 0.5× 112 6.4k
Stefania Natale Italy 5 4.5k 0.6× 2.6k 0.8× 1.0k 0.4× 843 0.7× 791 0.7× 8 5.1k

Countries citing papers authored by Ester Vanni

Since Specialization
Citations

This map shows the geographic impact of Ester Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Vanni more than expected).

Fields of papers citing papers by Ester Vanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Vanni. The network helps show where Ester Vanni may publish in the future.

Co-authorship network of co-authors of Ester Vanni

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Vanni. A scholar is included among the top collaborators of Ester Vanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Vanni. Ester Vanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manfredi, Marcello, Eleonora Conte, Elettra Barberis, et al.. (2018). Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease. Journal of Proteomics. 195. 138–149. 27 indexed citations
2.
Stefano, Cristina Di, Ester Vanni, S. Mirabella, et al.. (2018). Risk factors for arterial hypertension after liver transplantation. Journal of the American Society of Hypertension. 12(3). 220–229. 12 indexed citations
3.
Vanni, Ester, Elisabetta Bugianesi, & Giorgio Maria Saracco. (2015). Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?. Digestive and Liver Disease. 48(2). 105–111. 46 indexed citations
4.
Rosso, Chiara, Gian Paolo Caviglia, Maria Lorena Abate, et al.. (2015). Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis. Digestive and Liver Disease. 48(1). 55–61. 24 indexed citations
5.
Vanni, Ester & Elisabetta Bugianesi. (2013). Obesity and Liver Cancer. Clinics in Liver Disease. 18(1). 191–203. 53 indexed citations
6.
Vanni, Ester, Elisabetta Bugianesi, Anna Kotronen, et al.. (2010). From the metabolic syndrome to NAFLD or vice versa?. Digestive and Liver Disease. 42(5). 320–330. 408 indexed citations
7.
Fracanzani, Anna Ludovica, Luca Valenti, Elisabetta Bugianesi, et al.. (2010). Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity. Journal of Hepatology. 54(6). 1244–1249. 95 indexed citations
8.
Valenti, Luca, Ahmad Al‐Serri, Ann K. Daly, et al.. (2010). Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†. Hepatology. 51(4). 1209–1217. 497 indexed citations breakdown →
9.
Vanni, Ester, Maria Lorena Abate, E. Gentilcore, et al.. (2009). Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C #. Hepatology. 50(3). 697–706. 127 indexed citations
10.
Valenti, Luca, Anna Ludovica Fracanzani, Elisabetta Bugianesi, et al.. (2009). HFE Genotype, Parenchymal Iron Accumulation, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 138(3). 905–912. 220 indexed citations
11.
Fracanzani, Anna Ludovica, Luca Valenti, Elisabetta Bugianesi, et al.. (2008). Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes. Hepatology. 48(3). 792–798. 530 indexed citations breakdown →
12.
Valenti, Luca, Anna Ludovica Fracanzani, Paola Dongiovanni, et al.. (2007). Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study. The American Journal of Gastroenterology. 102(6). 1251–1258. 220 indexed citations
13.
Bugianesi, Elisabetta, Ester Vanni, & Giulio Marchesini. (2007). NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Current Diabetes Reports. 7(3). 175–180. 51 indexed citations
14.
Bugianesi, Elisabetta, Giulio Marchesini, E. Gentilcore, et al.. (2006). Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Hepatology. 44(6). 1648–1655. 129 indexed citations
15.
Bugianesi, Elisabetta, E. Gentilcore, Rita Manini, et al.. (2005). A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease. The American Journal of Gastroenterology. 100(5). 1082–1090. 544 indexed citations breakdown →
16.
Villanova, Nicola, Simona Moscatiello, Stefano Ramilli, et al.. (2005). Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†. Hepatology. 42(2). 473–480. 507 indexed citations breakdown →
17.
Bugianesi, Elisabetta, Paola Manzini, Sergio D’Antico, et al.. (2004). Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology. 39(1). 179–187. 345 indexed citations
18.
Marchesini, Giulio, Elisabetta Bugianesi, Gabriele Forlani, et al.. (2003). Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome. Hepatology. 37(4). 917–923. 2144 indexed citations breakdown →
19.
Marchesini, Giulio, Elisabetta Bugianesi, Gabriele Forlani, et al.. (2003). Non-alcoholic steatohepatitis in patients cared in metabolic units. Diabetes Research and Clinical Practice. 63(2). 143–151. 15 indexed citations
20.
Bugianesi, Elisabetta, Nicola Leone, Ester Vanni, et al.. (2002). Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 123(1). 134–140. 1142 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stergios Kechagias Breakdown of academic impact, for papers by Yao‐Chang Liu Breakdown of academic impact, for papers by Mattias Ekstedt Breakdown of academic impact, for papers by Shivakumar Chitturi Breakdown of academic impact, for papers by Aaron B. Koenig Breakdown of academic impact, for papers by Janus P. Ong Breakdown of academic impact, for papers by Christine G. Janney Breakdown of academic impact, for papers by Sven Francque Breakdown of academic impact, for papers by Paola Loria Breakdown of academic impact, for papers by Stefania Natale
Rankless by CCL
2026